These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


423 related items for PubMed ID: 28343355

  • 1. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.
    Picard C, Lega JC, Ranchin B, Cochat P, Cabrera N, Fabien N, Belot A.
    Pediatr Nephrol; 2017 Sep; 32(9):1537-1545. PubMed ID: 28343355
    [Abstract] [Full Text] [Related]

  • 2. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
    Smykał-Jankowiak K, Niemir ZI, Polcyn-Adamczak M.
    Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
    [Abstract] [Full Text] [Related]

  • 3. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H, Ekblom-Kullberg S, Miettinen A.
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
    Matrat A, Veysseyre-Balter C, Trolliet P, Villar E, Dijoud F, Bienvenu J, Fabien N.
    Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718
    [Abstract] [Full Text] [Related]

  • 5. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 6. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V, Stanković A, Cvetković T, Mitić B, Kostić S, Nedović J, Stamenković B.
    Srp Arh Celok Lek; 2014 Oct; 142(7-8):431-6. PubMed ID: 25233687
    [Abstract] [Full Text] [Related]

  • 7. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
    Emad G, Al-Barshomy SM.
    Saudi J Kidney Dis Transpl; 2020 Oct; 31(2):342-352. PubMed ID: 32394906
    [Abstract] [Full Text] [Related]

  • 8. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
    [Abstract] [Full Text] [Related]

  • 9. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun 02; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 10. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
    Kianmehr N, Khoshmirsafa M, Shekarabi M, Falak R, Haghighi A, Masoodian M, Seif F, Omidi F, Shirani F, Dadfar N.
    J Immunoassay Immunochem; 2021 Jul 04; 42(4):406-423. PubMed ID: 33788670
    [Abstract] [Full Text] [Related]

  • 11. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar 04; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 12. Cut-off values of immunological tests to identify patients at high risk of severe lupus nephritis.
    Gargiulo MLÁ, Khoury M, Gómez G, Grimaudo S, Suárez L, Collado MV, Sarano J.
    Medicina (B Aires); 2018 Mar 04; 78(5):329-335. PubMed ID: 30285925
    [Abstract] [Full Text] [Related]

  • 13. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
    Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M.
    Lupus; 2011 Oct 04; 20(12):1267-74. PubMed ID: 21813587
    [Abstract] [Full Text] [Related]

  • 14. Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China.
    Zhang CQ, Ren L, Gao F, Mu FY, You YQ, Liu YH.
    Clin Rheumatol; 2011 Jul 04; 30(7):967-73. PubMed ID: 21340499
    [Abstract] [Full Text] [Related]

  • 15. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
    Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, Li Vecchi M, Messa P, Sinico RA.
    Ann Rheum Dis; 2009 Feb 04; 68(2):234-7. PubMed ID: 18718989
    [Abstract] [Full Text] [Related]

  • 16. Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.
    Meyer OC, Nicaise-Roland P, Cadoudal N, Grootenboer-Mignot S, Palazzo E, Hayem G, Dieudé P, Chollet-Martin S.
    Arthritis Res Ther; 2009 Feb 04; 11(3):R87. PubMed ID: 19515233
    [Abstract] [Full Text] [Related]

  • 17. Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients.
    Jesus AA, Campos LM, Liphaus BL, Carneiro-Sampaio M, Mangueira CL, Rosseto EA, Silva CA, Scheinberg M.
    Rev Bras Reumatol; 2012 Dec 04; 52(6):976-81. PubMed ID: 23223707
    [Abstract] [Full Text] [Related]

  • 18. Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement.
    ElGendi SS, El-Sherif WT.
    Egypt J Immunol; 2009 Dec 04; 16(1):135-48. PubMed ID: 20726330
    [Abstract] [Full Text] [Related]

  • 19. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
    Jaekell HP, Trabandt A, Grobe N, Werle E.
    Lupus; 2006 Dec 04; 15(6):335-45. PubMed ID: 16830879
    [Abstract] [Full Text] [Related]

  • 20. Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis.
    Koutsonikoli A, Trachana M, Farmaki E, Tzimouli V, Pratsidou-Gertsi P, Printza N, Garyphallos A, Galanopoulou V, Kanakoudi-Tsakalidou F, Papachristou F.
    Clin Exp Immunol; 2017 Apr 04; 188(1):79-85. PubMed ID: 27936517
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.